BDPC Bromadol, the recently synthetic pain reliever, presents unique pharmacological characteristics. This compound mainly functions as a partial μ-opioid location stimulant, however shows notable action on the κ-opioid binding site and also. The combined influence results in the complicated set of effects, including analgesia, drowsiness, and